HBeAg-positive chronic hepatitis B: why do I treat my patients with pegylated interferon?-Reference-Cited by-同舟云学术

HBeAg-positive chronic hepatitis B: why do I treat my patients with pegylated interferon?

Published:2013-12-23 Issue: Volume:34 Page:112-119
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Kao Jia-Horng¹

Affiliation:

1. Department of Internal Medicine; Department of Medical Research; Graduate Institute of Clinical Medicine, and Hepatitis Research Center; National Taiwan University College of Medicine and Hospital; Taipei Taiwan

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.12400/fullpdf

Reference52 articles.

1. Global control of hepatitis B virus infection;Kao;Lancet Infect Dis,2002

2. Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma: epidemiologic and molecular biological aspects;Kao;Adv Cancer Res,2010

3. Chronic hepatitis B: update 2009;Lok;Hepatology,2009

4. EASL clinical practice guidelines: management of chronic hepatitis B;European Association For The Study Of The Liver;J Hepatol,2009

5. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update;Liaw;Hepatol Int,2012

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An intronic genetic variant of ZHX2 predicts response to pegylated interferon α therapy in HBeAg-positive chronic hepatitis B patients;Antiviral Research;2023-12

2. Expression Pattern of Cytokines in Patients with Chronic Hepatitis B Receiving PEGinterferon Therapy;International Journal of General Medicine;2023-05

3. Virological Treatment Monitoring for Chronic Hepatitis B;Viruses;2022-06-24

4. A Missense Variant in Granulysin is Associated with the Efficacy of Pegylated-Interferon-Alpha Therapy in Chinese Patients with HBeAg-Positive Chronic Hepatitis B;Pharmacogenomics and Personalized Medicine;2021-11

5. Whole genome deep sequencing analysis of viral quasispecies diversity and evolution in HBeAg seroconverters;JHEP Reports;2021-06